Biotech · Private company
Nilogen Oncosystems
Track this companyFree. Adds Nilogen Oncosystems to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 3D-EXPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- Evaluation of Response by RECISTPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLCRECRUITING · started Jul 21, 2022ClinicalTrials.gov NCT05332925 · fetched Nov 12, 2026
- Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLCEARLY_PHASE1 · UNKNOWN · started Mar 9, 2018ClinicalTrials.gov NCT03371992 · fetched Nov 12, 2026